Abstract 241
| Groups* | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| *Numbers in parentheses are multiple of Phase 3 clinical parameters | |||||
| Dose (mg/kg/hr) | 0 | 0.2 | 0.2 | 2.0 (10×) | 2.0 (10×) |
| MI | 1.2 (140%) | 1.0 | 1.2 (140%) | 1.0 | 1.2 |
| #Triggers | 1000 (5×) | 1000 (5×) | 1000 (5×) | 1000 (5×) | 1000 (5×) |
| n | 5 | 3 | 3 | 3 | 6 |